{"id":727151,"date":"2023-01-31T08:27:31","date_gmt":"2023-01-31T13:27:31","guid":{"rendered":"https:\/\/www.marketnewsdesk.com\/index.php\/seastar-medical-to-present-at-the-virtual-sequire-biotechnology-conference-on-february-2-2023\/"},"modified":"2023-01-31T08:27:31","modified_gmt":"2023-01-31T13:27:31","slug":"seastar-medical-to-present-at-the-virtual-sequire-biotechnology-conference-on-february-2-2023","status":"publish","type":"post","link":"https:\/\/www.marketnewsdesk.com\/index.php\/seastar-medical-to-present-at-the-virtual-sequire-biotechnology-conference-on-february-2-2023\/","title":{"rendered":"SeaStar Medical to Present at the Virtual Sequire Biotechnology Conference on February 2, 2023"},"content":{"rendered":"
\n

\n DENVER, Jan. 31, 2023 (GLOBE NEWSWIRE) — <\/strong>SeaStar Medical (Nasdaq: ICU), a medical technology company developing proprietary solutions to reduce the consequences of hyperinflammation on vital organs, announces that Eric Schlorff, CEO, will present a company overview at the virtual Sequire Biotechnology Conference on Thursday, February 2 at 3:30 p.m. Eastern time.<\/p>\n

To register for the event, visit the Sequire Biotechnology website<\/a>. An achieved webcast of the presentation will be available on the SeaStar Medical website<\/a>.<\/p>\n

\n About <\/strong>
\n Sequire<\/strong>\n <\/p>\n

Sequire is a premier investor intelligence and communications platform where companies can track their investors\u2019 behaviors and trends and use those insights to engage current and potential investors across marketing channels. More information is available at srax.com<\/a> and mysequire.com<\/a>.<\/p>\n

\n About SeaStar Medical, Inc.<\/strong>\n <\/p>\n

SeaStar Medical is a medical technology company focusing on redefining how extracorporeal therapies may reduce the consequences of excessive inflammation on vital organs. SeaStar Medical\u2019s novel technologies rely on science and innovation to provide life-saving solutions to critically ill patients. The Company is developing and commercializing extracorporeal therapies that target the effector cells that drive systemic inflammation, causing direct tissue damage and secreting a range of pro-inflammatory cytokines that initiate and propagate imbalanced immune responses. For more information visit\u00a0www.seastarmedical.com<\/strong><\/a>\u00a0or visit us on\u00a0LinkedIn<\/strong><\/a>\u00a0or\u00a0Twitter<\/strong><\/a>.<\/p>\n

\n Contacts: <\/strong>
\n
\n Media<\/u>
\n
PSC Consulting
Patty Caballero
(973) 348-5055
patty@pscconsulting.net<\/strong><\/a><\/p>\n

\n Investors<\/u>
\n
LHA Investor Relations
Jody Cain
(310) 691-7100
Jcain@lhai.com<\/strong><\/a>\u00a0<\/p>\n

# # #<\/p>\n<\/p>\n


\n
\n \n <\/div>\n

<\/div>\n","protected":false},"excerpt":{"rendered":"

DENVER, Jan. 31, 2023 (GLOBE NEWSWIRE) — SeaStar Medical (Nasdaq: ICU), a medical technology company developing proprietary solutions to reduce the consequences of hyperinflammation on vital organs, announces that Eric Schlorff, CEO, will present a company overview at the virtual Sequire Biotechnology Conference on Thursday, February 2 at 3:30 p.m. Eastern time. To register for the event, visit the Sequire Biotechnology website. An achieved webcast of the presentation will be available on the SeaStar Medical website. About Sequire Sequire is a premier investor intelligence and communications platform where companies can track their investors\u2019 behaviors and trends and use those insights to engage current and potential investors across marketing channels. More information is available at srax.com and mysequire.com. About SeaStar Medical, … <\/p>\n

Continue reading “SeaStar Medical to Present at the Virtual Sequire Biotechnology Conference on February 2, 2023”<\/span><\/a><\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[],"tags":[],"class_list":["post-727151","post","type-post","status-publish","format-standard","hentry"],"yoast_head":"\nSeaStar Medical to Present at the Virtual Sequire Biotechnology Conference on February 2, 2023 - Market Newsdesk<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.marketnewsdesk.com\/index.php\/seastar-medical-to-present-at-the-virtual-sequire-biotechnology-conference-on-february-2-2023\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"SeaStar Medical to Present at the Virtual Sequire Biotechnology Conference on February 2, 2023 - Market Newsdesk\" \/>\n<meta property=\"og:description\" content=\"DENVER, Jan. 31, 2023 (GLOBE NEWSWIRE) — SeaStar Medical (Nasdaq: ICU), a medical technology company developing proprietary solutions to reduce the consequences of hyperinflammation on vital organs, announces that Eric Schlorff, CEO, will present a company overview at the virtual Sequire Biotechnology Conference on Thursday, February 2 at 3:30 p.m. Eastern time. To register for the event, visit the Sequire Biotechnology website. An achieved webcast of the presentation will be available on the SeaStar Medical website. About Sequire Sequire is a premier investor intelligence and communications platform where companies can track their investors\u2019 behaviors and trends and use those insights to engage current and potential investors across marketing channels. More information is available at srax.com and mysequire.com. About SeaStar Medical, … Continue reading "SeaStar Medical to Present at the Virtual Sequire Biotechnology Conference on February 2, 2023"\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.marketnewsdesk.com\/index.php\/seastar-medical-to-present-at-the-virtual-sequire-biotechnology-conference-on-february-2-2023\/\" \/>\n<meta property=\"og:site_name\" content=\"Market Newsdesk\" \/>\n<meta property=\"article:published_time\" content=\"2023-01-31T13:27:31+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODczOTQ5MCM1MzgyNzQ0IzUwMDExMDY3Ng==\" \/>\n<meta name=\"author\" content=\"Newsdesk\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Newsdesk\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"1 minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/seastar-medical-to-present-at-the-virtual-sequire-biotechnology-conference-on-february-2-2023\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/seastar-medical-to-present-at-the-virtual-sequire-biotechnology-conference-on-february-2-2023\\\/\"},\"author\":{\"name\":\"Newsdesk\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"headline\":\"SeaStar Medical to Present at the Virtual Sequire Biotechnology Conference on February 2, 2023\",\"datePublished\":\"2023-01-31T13:27:31+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/seastar-medical-to-present-at-the-virtual-sequire-biotechnology-conference-on-february-2-2023\\\/\"},\"wordCount\":242,\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/seastar-medical-to-present-at-the-virtual-sequire-biotechnology-conference-on-february-2-2023\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODczOTQ5MCM1MzgyNzQ0IzUwMDExMDY3Ng==\",\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/seastar-medical-to-present-at-the-virtual-sequire-biotechnology-conference-on-february-2-2023\\\/\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/seastar-medical-to-present-at-the-virtual-sequire-biotechnology-conference-on-february-2-2023\\\/\",\"name\":\"SeaStar Medical to Present at the Virtual Sequire Biotechnology Conference on February 2, 2023 - Market Newsdesk\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/seastar-medical-to-present-at-the-virtual-sequire-biotechnology-conference-on-february-2-2023\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/seastar-medical-to-present-at-the-virtual-sequire-biotechnology-conference-on-february-2-2023\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODczOTQ5MCM1MzgyNzQ0IzUwMDExMDY3Ng==\",\"datePublished\":\"2023-01-31T13:27:31+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/seastar-medical-to-present-at-the-virtual-sequire-biotechnology-conference-on-february-2-2023\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/seastar-medical-to-present-at-the-virtual-sequire-biotechnology-conference-on-february-2-2023\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/seastar-medical-to-present-at-the-virtual-sequire-biotechnology-conference-on-february-2-2023\\\/#primaryimage\",\"url\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODczOTQ5MCM1MzgyNzQ0IzUwMDExMDY3Ng==\",\"contentUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODczOTQ5MCM1MzgyNzQ0IzUwMDExMDY3Ng==\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/seastar-medical-to-present-at-the-virtual-sequire-biotechnology-conference-on-february-2-2023\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"SeaStar Medical to Present at the Virtual Sequire Biotechnology Conference on February 2, 2023\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\",\"name\":\"Market Newsdesk\",\"description\":\"Latest Business News in Real Time\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\",\"name\":\"Newsdesk\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"caption\":\"Newsdesk\"},\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/author\\\/newsdesk\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"SeaStar Medical to Present at the Virtual Sequire Biotechnology Conference on February 2, 2023 - Market Newsdesk","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.marketnewsdesk.com\/index.php\/seastar-medical-to-present-at-the-virtual-sequire-biotechnology-conference-on-february-2-2023\/","og_locale":"en_US","og_type":"article","og_title":"SeaStar Medical to Present at the Virtual Sequire Biotechnology Conference on February 2, 2023 - Market Newsdesk","og_description":"DENVER, Jan. 31, 2023 (GLOBE NEWSWIRE) — SeaStar Medical (Nasdaq: ICU), a medical technology company developing proprietary solutions to reduce the consequences of hyperinflammation on vital organs, announces that Eric Schlorff, CEO, will present a company overview at the virtual Sequire Biotechnology Conference on Thursday, February 2 at 3:30 p.m. Eastern time. To register for the event, visit the Sequire Biotechnology website. An achieved webcast of the presentation will be available on the SeaStar Medical website. About Sequire Sequire is a premier investor intelligence and communications platform where companies can track their investors\u2019 behaviors and trends and use those insights to engage current and potential investors across marketing channels. More information is available at srax.com and mysequire.com. About SeaStar Medical, … Continue reading \"SeaStar Medical to Present at the Virtual Sequire Biotechnology Conference on February 2, 2023\"","og_url":"https:\/\/www.marketnewsdesk.com\/index.php\/seastar-medical-to-present-at-the-virtual-sequire-biotechnology-conference-on-february-2-2023\/","og_site_name":"Market Newsdesk","article_published_time":"2023-01-31T13:27:31+00:00","og_image":[{"url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODczOTQ5MCM1MzgyNzQ0IzUwMDExMDY3Ng==","type":"","width":"","height":""}],"author":"Newsdesk","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Newsdesk","Est. reading time":"1 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/seastar-medical-to-present-at-the-virtual-sequire-biotechnology-conference-on-february-2-2023\/#article","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/seastar-medical-to-present-at-the-virtual-sequire-biotechnology-conference-on-february-2-2023\/"},"author":{"name":"Newsdesk","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"headline":"SeaStar Medical to Present at the Virtual Sequire Biotechnology Conference on February 2, 2023","datePublished":"2023-01-31T13:27:31+00:00","mainEntityOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/seastar-medical-to-present-at-the-virtual-sequire-biotechnology-conference-on-february-2-2023\/"},"wordCount":242,"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/seastar-medical-to-present-at-the-virtual-sequire-biotechnology-conference-on-february-2-2023\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODczOTQ5MCM1MzgyNzQ0IzUwMDExMDY3Ng==","inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/seastar-medical-to-present-at-the-virtual-sequire-biotechnology-conference-on-february-2-2023\/","url":"https:\/\/www.marketnewsdesk.com\/index.php\/seastar-medical-to-present-at-the-virtual-sequire-biotechnology-conference-on-february-2-2023\/","name":"SeaStar Medical to Present at the Virtual Sequire Biotechnology Conference on February 2, 2023 - Market Newsdesk","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/seastar-medical-to-present-at-the-virtual-sequire-biotechnology-conference-on-february-2-2023\/#primaryimage"},"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/seastar-medical-to-present-at-the-virtual-sequire-biotechnology-conference-on-february-2-2023\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODczOTQ5MCM1MzgyNzQ0IzUwMDExMDY3Ng==","datePublished":"2023-01-31T13:27:31+00:00","author":{"@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"breadcrumb":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/seastar-medical-to-present-at-the-virtual-sequire-biotechnology-conference-on-february-2-2023\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.marketnewsdesk.com\/index.php\/seastar-medical-to-present-at-the-virtual-sequire-biotechnology-conference-on-february-2-2023\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/seastar-medical-to-present-at-the-virtual-sequire-biotechnology-conference-on-february-2-2023\/#primaryimage","url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODczOTQ5MCM1MzgyNzQ0IzUwMDExMDY3Ng==","contentUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODczOTQ5MCM1MzgyNzQ0IzUwMDExMDY3Ng=="},{"@type":"BreadcrumbList","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/seastar-medical-to-present-at-the-virtual-sequire-biotechnology-conference-on-february-2-2023\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.marketnewsdesk.com\/"},{"@type":"ListItem","position":2,"name":"SeaStar Medical to Present at the Virtual Sequire Biotechnology Conference on February 2, 2023"}]},{"@type":"WebSite","@id":"https:\/\/www.marketnewsdesk.com\/#website","url":"https:\/\/www.marketnewsdesk.com\/","name":"Market Newsdesk","description":"Latest Business News in Real Time","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.marketnewsdesk.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979","name":"Newsdesk","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","caption":"Newsdesk"},"url":"https:\/\/www.marketnewsdesk.com\/index.php\/author\/newsdesk\/"}]}},"_links":{"self":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/727151","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/comments?post=727151"}],"version-history":[{"count":0,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/727151\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/media?parent=727151"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/categories?post=727151"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/tags?post=727151"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}